Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica N McAlpine

Showing results (151-160 of 186) with videos related to

Pageof 19
Sort By:
The Journal of Pathology|June 2, 2012
Use of mutation profiles to refine the classification of endometrial carcinomasMelissa K McConechy, Jiarui Ding, Maggie Cu Cheang, et al.
Nature Methods|September 11, 2019
Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profilingAllen W Zhang, Ciara O'Flanagan, Elizabeth A Chavez, et al.
Genome Biology|October 19, 2019
Dissociation of solid tumor tissues with cold active protease for single-cell RNA-seq minimizes conserved collagenase-associated stress responsesCiara H O'Flanagan, Kieran R Campbell, Allen W Zhang, et al.
Plos One|July 15, 2011
Identification of novel therapeutic targets in microdissected clear cell ovarian cancersMichael P Stany, Vinod Vathipadiekal, Laurent Ozbun, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2015
Population distribution of lifetime risk of ovarian cancer in the United StatesCeleste Leigh Pearce, Daniel O Stram, Roberta B Ness, et al.
Gynecologic Oncology|February 8, 2023
Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancerAmy Jamieson, Jutta Huvila, Samuel Leung, et al.
BMC Cancer|March 29, 2018
Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkersCécile Le Page, Kurosh Rahimi, Martin Köbel, et al.
Cancer|April 1, 2021
Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysisJessica N McAlpine, Derek S Chiu, Remi A Nout, et al.
Neoplasia (New York, N.Y.)|September 18, 2025
Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomasDawn R Cochrane, Gian Luca Negri, Jutta Huvila, et al.
The Journal of Pathology|June 20, 2013
Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profilingAli Bashashati, Gavin Ha, Alicia Tone, et al.
Pageof 19

Showing results (151-160 of 186) with videos related to

Sort By:
Pageof 19
The Journal of Pathology|June 2, 2012
Use of mutation profiles to refine the classification of endometrial carcinomasMelissa K McConechy, Jiarui Ding, Maggie Cu Cheang, et al.
Nature Methods|September 11, 2019
Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profilingAllen W Zhang, Ciara O'Flanagan, Elizabeth A Chavez, et al.
Genome Biology|October 19, 2019
Dissociation of solid tumor tissues with cold active protease for single-cell RNA-seq minimizes conserved collagenase-associated stress responsesCiara H O'Flanagan, Kieran R Campbell, Allen W Zhang, et al.
Plos One|July 15, 2011
Identification of novel therapeutic targets in microdissected clear cell ovarian cancersMichael P Stany, Vinod Vathipadiekal, Laurent Ozbun, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2015
Population distribution of lifetime risk of ovarian cancer in the United StatesCeleste Leigh Pearce, Daniel O Stram, Roberta B Ness, et al.
Gynecologic Oncology|February 8, 2023
Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancerAmy Jamieson, Jutta Huvila, Samuel Leung, et al.
BMC Cancer|March 29, 2018
Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkersCécile Le Page, Kurosh Rahimi, Martin Köbel, et al.
Cancer|April 1, 2021
Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysisJessica N McAlpine, Derek S Chiu, Remi A Nout, et al.
Neoplasia (New York, N.Y.)|September 18, 2025
Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomasDawn R Cochrane, Gian Luca Negri, Jutta Huvila, et al.
The Journal of Pathology|June 20, 2013
Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profilingAli Bashashati, Gavin Ha, Alicia Tone, et al.
Pageof 19